Skip to main content
PBF logo

PBF — Investor Relations & Filings

Ticker · 1760 ISIN · TW0001760007 LEI · 54930078VUU2LBPR2729 TW Manufacturing
Open in API
Filings indexed 1,559 across all filing types
Latest filing 2026-05-21 Regulatory Filings
Country TW Taiwan
Listing TW 1760

About PBF

http://www.pbf.com.tw

Panion & BF Biotech Inc. is a biotechnology company focused on pharmaceutical research, development, and manufacturing. Founded in 1976, the firm operates across several core sectors, including new drug innovation, medical aesthetics, and nutritional supplements. It is recognized for its "Total Aging Management" strategy, which addresses the health needs of an aging population through a diverse product portfolio. Key offerings include treatments for chronic kidney disease, specifically phosphate binders, as well as dermatological drugs, hair care solutions, and rapid diagnostic technologies. The company integrates clinical-grade pharmaceutical standards into its consumer health and aesthetic products, serving markets in chronic disease care and preventative wellness.

Recent filings

Filing Released Lang Actions
本公司檸檬酸鐵原料藥上市登記進口案獲中國國家 藥監局核准
Regulatory Filings Classification · 90% confidence The document is a regulatory disclosure on the Taiwan Public Information Observatory by listed company 1760 寶齡富錦 announcing that its active pharmaceutical ingredient (ferric citrate) has been approved for registration by China’s NMPA. It provides factual event date, company relationship, background, and significance. It is not a full financial report or presentation but a general material event announcement, placing it in the fallback category for miscellaneous regulatory filings: RNS.
2026-05-21 Chinese
115年第1季財務報告書 — 202601_1760_AI1.pdf
Interim / Quarterly Report Classification · 95% confidence The document is titled “合併財務報告暨會計師核閱報告” for 民國一一五年及一一四年第一季 and includes a full accountants’ review report plus consolidated balance sheet, income statement, cash flow, statement of changes, and extensive notes. It contains actual financial statements for the quarter rather than merely announcing or linking to a report. This matches the definition of an interim/quarterly report. Q1 2026
2026-05-13 Chinese
115年第1季海外子公司投資
Interim / Quarterly Report Classification · 85% confidence The document is a Taiwanese public disclosure (“公開資訊觀測站”) titled “115年1季申報作業,” which translates to the first quarter reporting operations. It contains detailed financial data—investment balances, original investment amounts, and recognized profit or loss for the quarter—rather than merely announcing availability of a report. This is substantive quarterly financial information, consistent with an Interim/Quarterly Report (IR). Q1 2026
2026-05-13 Chinese
115年第1季大陸投資
Regulatory Filings Classification · 75% confidence The document is a standalone schedule listing the company’s investments in Mainland China with detailed tables of capital amounts, investment methods, and approvals. It does not constitute a full interim or annual financial report, nor is it an announcement of an upcoming report; rather it is a specific regulatory disclosure filed via the public information platform. It does not match any of the more specific categories (earnings release, M&A, director dealings, etc.), so it falls into the fallback category of a general regulatory filing.
2026-05-13 Chinese
115年第1季權益變動表
Regulatory Filings Classification · 20% confidence The document is an error message indicating a page cannot be accessed, with no substantive corporate filing content. It does not match any specific report type and serves as a generic notice, so it falls under the fallback category “Regulatory Filings” (RNS).
2026-05-13 Chinese
115年第1季現金流量表
Interim / Quarterly Report Classification · 87% confidence The document is a consolidated cash flow statement covering the first quarter of the fiscal year (民國115年第1季 vs 114年第1季), with detailed financial figures (cash flow from operating, investing, and financing activities). It contains actual interim period financial statements, not merely an announcement. This matches the definition of an Interim / Quarterly Report (IR). Q1 2026
2026-05-13 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.